HCM
Highbridge Capital Management Portfolio holdings
AUM
$1.94B
1-Year Return
13.79%
This Quarter Return
+2.57%
1 Year Return
+13.79%
3 Year Return
+28.57%
5 Year Return
+61.78%
10 Year Return
+80.04%
AUM
$5.2B
AUM Growth
+$119M
(+2.3%)
Cap. Flow
-$1.59B
Cap. Flow
% of AUM
-30.61%
Top 10 Holdings %
Top 10 Hldgs %
20.58%
Holding
1,603
New
459
Increased
244
Reduced
228
Closed
473
Top Buys
| 1 |
Alibaba
BABA
|
+$51.8M |
| 2 |
AGN.PRA
Allergan plc.
AGN.PRA
|
+$36.9M |
| 3 |
Danaher
DHR
|
+$34.3M |
| 4 |
DaVita
DVA
|
+$30.7M |
| 5 |
Oracle
ORCL
|
+$30.4M |
Top Sells
| 1 |
Coca-Cola Europacific Partners
CCEP
|
+$66.6M |
| 2 |
eBay
EBAY
|
+$52.3M |
| 3 |
SWNC
Southwestern Energy Company
SWNC
|
+$49.7M |
| 4 |
Tyson Foods
TSN
|
+$46.1M |
| 5 |
Procter & Gamble
PG
|
+$44.1M |
Sector Composition
| 1 | Healthcare | 9.42% |
| 2 | Technology | 8.27% |
| 3 | Consumer Discretionary | 7.67% |
| 4 | Consumer Staples | 6.2% |
| 5 | Industrials | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
DuPont de Nemours
DD
$32.4B
| $275K | ﹤0.01% |
+2,624
| New | +$275K |
|
802
Seres Therapeutics
MCRB
$154M
| $275K | ﹤0.01% |
+1,118
| New | +$275K |
|
803
Neurogene
NGNE
$273M
| $274K | ﹤0.01% |
+1,023
| New | +$274K |
|
|
USCR
804
DELISTED
U S Concrete, Inc.
USCR
| $274K | ﹤0.01% |
5,948
-7,556
| -56% | -$348K |
|
|
AKRX
805
DELISTED
Akorn, Inc.
AKRX
| $274K | ﹤0.01% |
10,066
-17,706
| -64% | -$482K |
|
806
Aflac
AFL
$57.8B
| $273K | ﹤0.01% |
+7,608
| New | +$273K |
|
807
CommScope
COMM
$3.66B
| $273K | ﹤0.01% |
+9,064
| New | +$273K |
|
|
AMCC
808
DELISTED
Applied Micro Circuits Corporation New
AMCC
| $269K | ﹤0.01% |
+38,687
| New | +$269K |
|
809
Monster Beverage
MNST
$62.2B
| $267K | ﹤0.01% |
+10,914
| New | +$267K |
|
810
Heron Therapeutics
HRTX
$198M
| $266K | ﹤0.01% |
+15,445
| New | +$266K |
|
811
TransAlta
TAC
$3.7B
| $266K | ﹤0.01% |
59,900
+11,300
| +23% | +$50.2K |
|
|
LCI
812
DELISTED
Lannett Company, Inc.
LCI
| $266K | ﹤0.01% |
+2,508
| New | +$266K |
|
813
INNOVATE Corp
VATE
$66.7M
| $265K | ﹤0.01% |
+4,860
| New | +$265K |
|
814
Tri Pointe Homes
TPH
$3.13B
| $262K | ﹤0.01% |
+19,864
| New | +$262K |
|
|
AIMT
815
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $261K | ﹤0.01% |
17,394
-3,877
| -18% | -$58.2K |
|
816
Regenxbio
RGNX
$483M
| $258K | ﹤0.01% |
18,359
+8,142
| +80% | +$114K |
|
817
Dillards
DDS
$9.03B
| $257K | ﹤0.01% |
+4,087
| New | +$257K |
|
818
MBIA
MBI
$377M
| $255K | ﹤0.01% |
+32,750
| New | +$255K |
|
819
Pfizer
PFE
$141B
| $254K | ﹤0.01% |
7,905
-127,604
| -94% | -$4.1M |
|
820
LCI Industries
LCII
$2.5B
| $253K | ﹤0.01% |
+2,586
| New | +$253K |
|
821
Innospec
IOSP
$2.07B
| $248K | ﹤0.01% |
+4,074
| New | +$248K |
|
|
AERI
822
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $247K | ﹤0.01% |
+6,534
| New | +$247K |
|
823
MillerKnoll
MLKN
$1.42B
| $246K | ﹤0.01% |
+8,591
| New | +$246K |
|
824
Pitney Bowes
PBI
$1.94B
| $246K | ﹤0.01% |
13,561
-84,479
| -86% | -$1.53M |
|
825
TTM Technologies
TTMI
$5.07B
| $246K | ﹤0.01% |
+21,539
| New | +$246K |
|